See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Multifocal choroiditis (MFC) is generally treated with steroid medication that can be taken orally or injected into the affected eye. These treatments may be successful in managing symptoms, though there is no permanent cure for the disease and symptoms may return. If a person no longer responds to steroid treatment, drugs that suppress the immune system, such as cyclosporine, may be recommended. People with more severe vision loss may also benefit from laser therapy. Frequent monitoring by an ophthalmologist is recommended to determine how well treatment is working.
Last updated: 3/7/2016
- Stephen Foster. Multifocal Choroiditis and Panuveities (MCOP): Case Report. The Ocular Immunology and Uveitis Foundation. http://www.uveitis.org/multifocal-choroiditis-and-panuveitis. Accessed 3/7/2016.
- Courtney M Crawford and Okezie Igboeli. A Review of the Inflammatory Chorioretinopathies: The White Dot Syndromes. International Scholarly Research Notices. May, 2013; http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833360/.
- ClinicalTrials.gov lists trials that are studying or have studied Multifocal choroiditis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.